EP Patent

EP2246086A3 — Aerosol drug delivery device incorporating percussively activated heating unit

Assigned to Alexza Pharmaceuticals Inc · Expires 2012-11-21 · 13y expired

What this patent protects

Aerosol drug delivery devices (10) incorporating percussively activated heat packages (32) are disclosed. The heat packages include a percussive igniter (40) and a fuel (50) capable of undergoing an exothermic oxidation-reduction reaction when ignited by the percussive igniter. T…

USPTO Abstract

Aerosol drug delivery devices (10) incorporating percussively activated heat packages (32) are disclosed. The heat packages include a percussive igniter (40) and a fuel (50) capable of undergoing an exothermic oxidation-reduction reaction when ignited by the percussive igniter. The drug delivery devices disclosed can be activated by an actuation mechanism to vaporize a thin solid film (56) comprising a drug disposed on the exterior of a heat package. Metal coordination complexes of volatile drugs, and in particular nicotine, from which the drug can be selectively vaporized when heated are also disclosed. The use of aerosol drug delivery devices comprising thin films of nicotine metal salt complexes for the treatment of nicotine craving and for effecting smoking cessation are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2246086A3
Jurisdiction
EP
Classification
Expires
2012-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Alexza Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.